Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001357072 | SCV001552408 | pathogenic | Carcinoma of colon | no assertion criteria provided | clinical testing | The c.367-?_645+?del alteration has been previously reported by our laboratory in three families with Lynch syndrome. This alteration is predicted to cause a deletion of EXON03 and to result in a frameshift, a truncated or absent protein and loss of function. Loss of function variants of the MSH2 gene are an established mechanism of disease for Lynch syndrome. Please note, the precise breakpoints of this deletion were not determined and further study would be necessary to confirm the effect of this alteration at the mRNA or protein level. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as pathogenic. |